Resultados da busca - Laurynas Mockeliunas

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment por Lina Keutzer, Laurynas Mockeliunas, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Onno W. Akkerman, Ulrika S. H. Simonsson

Connect to this object online.

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling por Rob C. vanWijk, Laurynas Mockeliunas, Caryn M. Upton, Jonathan Peter, Andreas H. Diacon, Ulrika S. H. Simonsson

Connect to this object online.

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis por Laurynas Mockeliunas, Lina Keutzer, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Lotte M. G. Hulskotte, Onno W. Akkerman, Ulrika S. H. Simonsson

Connect to this object online.

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development por Laurynas Mockeliunas, Alan Faraj, Rob C. van Wijk, Caryn M. Upton, Gerben van den Hoogen, Andreas H. Diacon, Ulrika S. H. Simonsson

Connect to this object online.